A significant advance in cancer investigation is emerging with the use of nanobodies to re-engage dysfunctional p53. This crucial cancer protector protein is frequently disabled in many types of cancer, resulting https://thesocialvibes.com/story7534489/mini-antibodies-restore-tumor-suppressor-p53-new-potential-pathway-for-cancer-management